Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Raballand
A. Raballand
Medicine
Pathology
Cancer research
Pancreatic cancer
Immunology
5
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Mélanome cutané avec atteinte ganglionnaire : valeur pronostique de l’expression nucléaire du récepteur de chémokine CXCR4
2014
Annales De Dermatologie Et De Venereologie
L. Deschamps
S. Faivre
M. Serova
A. de Gramont
A. Raballand
S. Albert
I. Scheer
E. Marinho
B. Crickx
E. Raymond
Anne Couvelard
E. Maubec
Show All
Source
Cite
Save
Citations (0)
402 Dual Inhibition of the MEK and the PI3K-Akt-mTOR Pathways Using GSK1120212 (or UO126) and Everolimus Overcomes Resistance to MEK Inhibitors Used as Single Agents in Pancreatic Cancer Cells
2012
European Journal of Cancer
Cindy Neuzillet
M. Serova
A. Raballand
Lucile Astorgues-Xerri
M.E. Riveiro
A. de Gramont
Philippe Ruszniewski
P. Hammel
S. Faivre
E. Raymond
Show All
Source
Cite
Save
Citations (0)
398 Benchmarking the Allosteric MEK Inhibitors UO126, AZD6244, AS703026, and GSK1120212 Shows Differences in Potency to Inhibit ERK Phosphorylation, Proliferation, and Invasion in Pancreatic Cancer Models
2012
European Journal of Cancer
Cindy Neuzillet
M. Serova
A. Raballand
Lucile Astorgues-Xerri
M.E. Riveiro
A. de Gramont
Philippe Ruszniewski
P. Hammel
S. Faivre
E. Raymond
Show All
Source
Cite
Save
Citations (1)
1